{"transactions":[{"id":831552,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-03-23T21:08:39.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":931,"price":19.12,"value":17800.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":92429,"source":{"system":"sec-edgar","filing":"0001628280-26-020577","document":"wk-form4_1774300116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020577/wk-form4_1774300116.xml","form_type":"4"}},{"id":859862,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-03-05T22:10:11.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":219,"price":20.74,"value":4542.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":93360,"source":{"system":"sec-edgar","filing":"0001628280-26-015337","document":"wk-form4_1772748608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026015337/wk-form4_1772748608.xml","form_type":"4"}},{"id":880779,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:29.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":5734,"price":22.65,"value":129875.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":93579,"source":{"system":"sec-edgar","filing":"0001628280-26-012472","document":"wk-form4_1772146526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012472/wk-form4_1772146526.xml","form_type":"4"}},{"id":880778,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:29.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":23548,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":99313,"source":{"system":"sec-edgar","filing":"0001628280-26-012472","document":"wk-form4_1772146526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012472/wk-form4_1772146526.xml","form_type":"4"}},{"id":943689,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-01-08T22:04:14.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":241,"price":25.59,"value":6167.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":75765,"source":{"system":"sec-edgar","filing":"0001628280-26-001384","document":"wk-form4_1767909852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026001384/wk-form4_1767909852.xml","form_type":"4"}},{"id":966118,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-12-17T22:26:08.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":713,"price":24.46,"value":17439.98,"ownership":{"direct":true},"balance_after":76006,"source":{"system":"sec-edgar","filing":"0001628280-25-057722","document":"wk-form4_1766010365.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025057722/wk-form4_1766010365.xml","form_type":"4"}},{"id":966117,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-12-17T22:26:08.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":233,"price":25.13,"value":5855.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":76719,"source":{"system":"sec-edgar","filing":"0001628280-25-057722","document":"wk-form4_1766010365.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025057722/wk-form4_1766010365.xml","form_type":"4"}},{"id":986397,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-11-28T22:35:31.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":217,"price":26.74,"value":5802.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":76952,"source":{"system":"sec-edgar","filing":"0001628280-25-054281","document":"wk-form4_1764369329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025054281/wk-form4_1764369329.xml","form_type":"4"}},{"id":1019736,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-10-14T21:30:28.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":188,"price":27.36,"value":5143.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":77169,"source":{"system":"sec-edgar","filing":"0001628280-25-045016","document":"wk-form4_1760477426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025045016/wk-form4_1760477426.xml","form_type":"4"}},{"id":1038656,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-09-17T21:43:32.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":714,"price":25.61,"value":18285.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024."}],"balance_after":77357,"source":{"system":"sec-edgar","filing":"0001837756-25-000005","document":"wk-form4_1758145409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000183775625000005/wk-form4_1758145409.xml","form_type":"4"}},{"id":1041001,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-09-15T21:02:01.000Z","date":"2025-09-11","kind":"sale","planned":true,"acquired":false,"shares":233,"price":26.83,"value":6251.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":78071,"source":{"system":"sec-edgar","filing":"0001837756-25-000003","document":"wk-form4_1757970119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000183775625000003/wk-form4_1757970119.xml","form_type":"4"}},{"id":1054153,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-08-28T21:07:06.000Z","date":"2025-08-26","kind":"sale","planned":true,"acquired":false,"shares":219,"price":25.44,"value":5571.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":78304,"source":{"system":"sec-edgar","filing":"0001628280-25-041300","document":"wk-form4_1756415220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025041300/wk-form4_1756415220.xml","form_type":"4"}},{"id":1090327,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-07-09T21:54:44.000Z","date":"2025-07-07","kind":"sale","planned":true,"acquired":false,"shares":198,"price":22.27,"value":4409.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":78523,"source":{"system":"sec-edgar","filing":"0001628280-25-034685","document":"wk-form4_1752098077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025034685/wk-form4_1752098077.xml","form_type":"4"}},{"id":1106969,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-06-18T21:44:16.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":711,"price":22.23,"value":15805.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024."}],"balance_after":78721,"source":{"system":"sec-edgar","filing":"0001628280-25-032190","document":"wk-form4_1750283050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025032190/wk-form4_1750283050.xml","form_type":"4"}},{"id":1114245,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-06-12T21:23:58.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":235,"price":23.7,"value":5569.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":79432,"source":{"system":"sec-edgar","filing":"0001628280-25-031099","document":"wk-form4_1749763432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025031099/wk-form4_1749763432.xml","form_type":"4"}},{"id":1129935,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-05-30T22:09:10.000Z","date":"2025-05-28","kind":"sale","planned":true,"acquired":false,"shares":217,"price":22.46,"value":4873.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":79667,"source":{"system":"sec-edgar","filing":"0001628280-25-028707","document":"wk-form4_1748642842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025028707/wk-form4_1748642842.xml","form_type":"4"}},{"id":1173649,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-04-11T21:49:23.000Z","date":"2025-04-09","kind":"sale","planned":true,"acquired":false,"shares":210,"price":20.11,"value":4223.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":79884,"source":{"system":"sec-edgar","filing":"0001628280-25-017587","document":"wk-form4_1744408157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025017587/wk-form4_1744408157.xml","form_type":"4"}},{"id":1181304,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-04-03T21:48:43.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":5771,"price":22.66,"value":130770.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":80094,"source":{"system":"sec-edgar","filing":"0001628280-25-016637","document":"wk-form4_1743716917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025016637/wk-form4_1743716917.xml","form_type":"4"}},{"id":1196286,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:10:53.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":21789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 175% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":85865,"source":{"system":"sec-edgar","filing":"0001628280-25-014194","document":"wk-form4_1742512247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014194/wk-form4_1742512247.xml","form_type":"4"}},{"id":1196285,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:10:53.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":15279,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2025 compensation."}],"balance_after":64076,"source":{"system":"sec-edgar","filing":"0001628280-25-014194","document":"wk-form4_1742512247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014194/wk-form4_1742512247.xml","form_type":"4"}},{"id":1196277,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:08:25.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":2695,"price":25.44,"value":68560.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4 amendment has been filed to correct the amount of securities reported in a Form 4 filed on March 18, 2025. The Form 4 included a sale of 5,632 shares that was improperly included under the reporting person. The correct amount of securities should have been reported as 2,695 in the Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.90 to $25.97, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":48797,"source":{"system":"sec-edgar","filing":"0001628280-25-014185","document":"wk-form4a_1742512099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014185/wk-form4a_1742512099.xml","form_type":"4/A","original_submission_date":"2025-03-18"}},{"id":1202336,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:59:49.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":2695,"price":25.44,"value":68560.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.90 to $25.97, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43165,"source":{"system":"sec-edgar","filing":"0001628280-25-013585","document":"wk-form4_1742335183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025013585/wk-form4_1742335183.xml","form_type":"4"}},{"id":1202335,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:59:49.000Z","date":"2025-03-14","kind":"sale","planned":true,"acquired":false,"shares":5632,"price":24.96,"value":140574.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.18 to $25.91, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":45860,"source":{"system":"sec-edgar","filing":"0001628280-25-013585","document":"wk-form4_1742335183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025013585/wk-form4_1742335183.xml","form_type":"4"}},{"id":1208512,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-03-13T21:26:25.000Z","date":"2025-03-12","kind":"sale","planned":true,"acquired":false,"shares":7324,"price":26.34,"value":192914.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024."}],"balance_after":51492,"source":{"system":"sec-edgar","filing":"0001628280-25-012680","document":"wk-form4_1741901179.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025012680/wk-form4_1741901179.xml","form_type":"4"}},{"id":1208511,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-03-13T21:26:25.000Z","date":"2025-03-11","kind":"sale","planned":true,"acquired":false,"shares":1091,"price":25,"value":27275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":58816,"source":{"system":"sec-edgar","filing":"0001628280-25-012680","document":"wk-form4_1741901179.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025012680/wk-form4_1741901179.xml","form_type":"4"}},{"id":1224606,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-03-05T22:13:17.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":284,"price":25.46,"value":7230.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":59907,"source":{"system":"sec-edgar","filing":"0001628280-25-010563","document":"wk-form4_1741212791.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025010563/wk-form4_1741212791.xml","form_type":"4"}},{"id":1268566,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-02-14T22:46:31.000Z","date":"2025-02-12","kind":"sale","planned":true,"acquired":false,"shares":53,"price":26.54,"value":1406.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":60191,"source":{"system":"sec-edgar","filing":"0001628280-25-005839","document":"wk-form4_1739573185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025005839/wk-form4_1739573185.xml","form_type":"4"}},{"id":1307236,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2025-01-09T00:11:16.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":240,"price":27.02,"value":6484.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":60244,"source":{"system":"sec-edgar","filing":"0001628280-25-000987","document":"wk-form4_1736381469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025000987/wk-form4_1736381469.xml","form_type":"4"}},{"id":1348642,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-11-29T22:29:42.000Z","date":"2024-11-26","kind":"sale","planned":true,"acquired":false,"shares":216,"price":27.2,"value":5875.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":60484,"source":{"system":"sec-edgar","filing":"0001628280-24-049477","document":"wk-form4_1732919376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024049477/wk-form4_1732919376.xml","form_type":"4"}},{"id":1378527,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-11-01T23:02:07.000Z","date":"2024-10-30","kind":"sale","planned":true,"acquired":false,"shares":203,"price":23.15,"value":4699.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":60700,"source":{"system":"sec-edgar","filing":"0001628280-24-044815","document":"wk-form4_1730502121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024044815/wk-form4_1730502121.xml","form_type":"4"}},{"id":1404150,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-09-18T21:45:03.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":229,"price":25.12,"value":5752.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":60903,"source":{"system":"sec-edgar","filing":"0001628280-24-040831","document":"wk-form4_1726695897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024040831/wk-form4_1726695897.xml","form_type":"4"}},{"id":1404149,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-09-18T21:45:03.000Z","date":"2024-08-21","kind":"sale","planned":true,"acquired":false,"shares":64,"price":25.61,"value":1639.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":61132,"source":{"system":"sec-edgar","filing":"0001628280-24-040831","document":"wk-form4_1726695897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024040831/wk-form4_1726695897.xml","form_type":"4"}},{"id":1404148,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-09-18T21:45:03.000Z","date":"2024-07-19","kind":"sale","planned":true,"acquired":false,"shares":300,"price":21.01,"value":6303.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":61196,"source":{"system":"sec-edgar","filing":"0001628280-24-040831","document":"wk-form4_1726695897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024040831/wk-form4_1726695897.xml","form_type":"4"}},{"id":1404147,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-09-18T21:45:03.000Z","date":"2024-07-11","kind":"sale","planned":true,"acquired":false,"shares":187,"price":20.54,"value":3840.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":61496,"source":{"system":"sec-edgar","filing":"0001628280-24-040831","document":"wk-form4_1726695897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024040831/wk-form4_1726695897.xml","form_type":"4"}},{"id":1461430,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-07-03T21:02:37.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":21.03,"value":63090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-15-2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.72 to $21.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":61683,"source":{"system":"sec-edgar","filing":"0001628280-24-031167","document":"wk-form4_1720040550.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024031167/wk-form4_1720040550.xml","form_type":"4"}},{"id":1497225,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-05-31T21:05:39.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":345,"price":21.78,"value":7514.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":64683,"source":{"system":"sec-edgar","filing":"0001628280-24-026083","document":"wk-form4_1717189531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024026083/wk-form4_1717189531.xml","form_type":"4"}},{"id":1507988,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-05-21T12:13:02.000Z","date":"2024-05-17","kind":"sale","planned":true,"acquired":false,"shares":57,"price":22.18,"value":1264.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":65028,"source":{"system":"sec-edgar","filing":"0001628280-24-024445","document":"wk-form4_1716293573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024024445/wk-form4_1716293573.xml","form_type":"4"}},{"id":1537193,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-04-23T23:15:00.000Z","date":"2024-04-22","kind":"sale","planned":true,"acquired":false,"shares":410,"price":16.5,"value":6765.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":65085,"source":{"system":"sec-edgar","filing":"0001628280-24-017499","document":"wk-form4_1713914088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024017499/wk-form4_1713914088.xml","form_type":"4"}},{"id":1537192,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-04-23T23:15:00.000Z","date":"2024-04-18","kind":"sale","planned":true,"acquired":false,"shares":348,"price":15.31,"value":5327.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":65495,"source":{"system":"sec-edgar","filing":"0001628280-24-017499","document":"wk-form4_1713914088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024017499/wk-form4_1713914088.xml","form_type":"4"}},{"id":1551649,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-04-03T21:17:34.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":17.65,"value":70600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-15-2023."}],"balance_after":65843,"source":{"system":"sec-edgar","filing":"0001628280-24-014662","document":"wk-form4_1712179040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024014662/wk-form4_1712179040.xml","form_type":"4"}},{"id":1582757,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:42:27.000Z","date":"2024-03-12","kind":"sale","planned":true,"acquired":false,"shares":4361,"price":16.6,"value":72392.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":69843,"source":{"system":"sec-edgar","filing":"0001628280-24-010741","document":"wk-form4_1710294122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010741/wk-form4_1710294122.xml","form_type":"4"}},{"id":1582756,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:42:27.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":269,"price":17.42,"value":4685.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":74204,"source":{"system":"sec-edgar","filing":"0001628280-24-010741","document":"wk-form4_1710294122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010741/wk-form4_1710294122.xml","form_type":"4"}},{"id":1582755,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:42:27.000Z","date":"2024-03-08","kind":"grant","planned":true,"acquired":true,"shares":17523,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 125% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":74473,"source":{"system":"sec-edgar","filing":"0001628280-24-010741","document":"wk-form4_1710294122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010741/wk-form4_1710294122.xml","form_type":"4"}},{"id":1582754,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:42:27.000Z","date":"2024-03-08","kind":"grant","planned":true,"acquired":true,"shares":15144,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2024 compensation."}],"balance_after":56950,"source":{"system":"sec-edgar","filing":"0001628280-24-010741","document":"wk-form4_1710294122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010741/wk-form4_1710294122.xml","form_type":"4"}},{"id":1623693,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-02-23T22:52:15.000Z","date":"2024-02-21","kind":"sale","planned":true,"acquired":false,"shares":58,"price":17.35,"value":1006.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":41806,"source":{"system":"sec-edgar","filing":"0001628280-24-006710","document":"wk-form4_1708728723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024006710/wk-form4_1708728723.xml","form_type":"4"}},{"id":1671470,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-01-25T22:10:38.000Z","date":"2024-01-23","kind":"sale","planned":true,"acquired":false,"shares":336,"price":17.11,"value":5748.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":41864,"source":{"system":"sec-edgar","filing":"0001628280-24-002257","document":"wk-form4_1706220628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024002257/wk-form4_1706220628.xml","form_type":"4"}},{"id":1673592,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2024-01-23T22:29:37.000Z","date":"2024-01-19","kind":"sale","planned":true,"acquired":false,"shares":862,"price":16.76,"value":14447.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":42200,"source":{"system":"sec-edgar","filing":"0001628280-24-001980","document":"wk-form4_1706048966.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024001980/wk-form4_1706048966.xml","form_type":"4"}},{"id":1724594,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-12-05T00:15:12.000Z","date":"2023-12-01","kind":"sale","planned":true,"acquired":false,"shares":394,"price":12.37,"value":4873.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":43062,"source":{"system":"sec-edgar","filing":"0001628280-23-040676","document":"wk-form4_1701735302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023040676/wk-form4_1701735302.xml","form_type":"4"}},{"id":1741564,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-11-15T15:41:39.000Z","date":"2023-11-13","kind":"sale","planned":true,"acquired":false,"shares":76,"price":10.77,"value":818.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":43456,"source":{"system":"sec-edgar","filing":"0001628280-23-039099","document":"wk-form4_1700062891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023039099/wk-form4_1700062891.xml","form_type":"4"}},{"id":1794690,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-08-29T21:48:07.000Z","date":"2023-08-25","kind":"sale","planned":true,"acquired":false,"shares":347,"price":10.99,"value":3813.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":43532,"source":{"system":"sec-edgar","filing":"0001628280-23-030909","document":"wk-form4_1693345657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023030909/wk-form4_1693345657.xml","form_type":"4"}},{"id":1806710,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-08-16T20:46:30.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":104,"price":12.38,"value":1287.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":43879,"source":{"system":"sec-edgar","filing":"0001628280-23-029681","document":"wk-form4_1692218782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023029681/wk-form4_1692218782.xml","form_type":"4"}},{"id":1823168,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-07-26T22:08:59.000Z","date":"2023-07-24","kind":"sale","planned":true,"acquired":false,"shares":462,"price":19.5,"value":9009.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":43983,"source":{"system":"sec-edgar","filing":"0001628280-23-025783","document":"wk-form4_1690409329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023025783/wk-form4_1690409329.xml","form_type":"4"}},{"id":1871090,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-06-03T00:00:54.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":337,"price":23.21,"value":7821.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":44445,"source":{"system":"sec-edgar","filing":"0001437749-23-016543","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923016543/rdgdoc.xml","form_type":"4"}},{"id":1890407,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-05-18T01:52:28.000Z","date":"2023-05-15","kind":"sale","planned":true,"acquired":false,"shares":72,"price":18.71,"value":1347.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":44782,"source":{"system":"sec-edgar","filing":"0001437749-23-015003","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923015003/rdgdoc.xml","form_type":"4"}},{"id":1892577,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Restricted Stock Award","published_at":"2023-05-17T01:47:48.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":false,"shares":2795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 100% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 100% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2795},"source":{"system":"sec-edgar","filing":"0001437749-23-014860","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923014860/rdgdoc.xml","form_type":"4/A","original_submission_date":"2023-04-10"}},{"id":1892576,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-05-17T01:47:48.000Z","date":"2023-04-06","kind":"sale","planned":true,"acquired":false,"shares":739,"price":20.03,"value":14802.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This reflects the total amount beneficially owned by the reporting person as of April 10, 2023. Subsequent Form 4's filed by the reporting person after April 10, 2023 do not currently reflect the vesting of the 2,795 shares."}],"balance_after":45146,"source":{"system":"sec-edgar","filing":"0001437749-23-014860","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923014860/rdgdoc.xml","form_type":"4/A","original_submission_date":"2023-04-10"}},{"id":1892575,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-05-17T01:47:48.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":true,"shares":2795,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 100% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 100% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":45885,"source":{"system":"sec-edgar","filing":"0001437749-23-014860","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923014860/rdgdoc.xml","form_type":"4/A","original_submission_date":"2023-04-10"}},{"id":1915913,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-04-21T23:00:11.000Z","date":"2023-04-19","kind":"sale","planned":true,"acquired":false,"shares":292,"price":19.33,"value":5644.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 7/17/2020"}],"balance_after":42059,"source":{"system":"sec-edgar","filing":"0001437749-23-010841","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923010841/rdgdoc.xml","form_type":"4"}},{"id":1922552,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-04-10T23:01:36.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":739,"price":20.03,"value":14802.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":42351,"source":{"system":"sec-edgar","filing":"0001437749-23-009874","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923009874/rdgdoc.xml","form_type":"4"}},{"id":1976697,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-03-04T00:01:23.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1022,"price":22.75,"value":23250.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":43090,"source":{"system":"sec-edgar","filing":"0001437749-23-005440","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923005440/rdgdoc.xml","form_type":"4"}},{"id":2020936,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-02-14T00:00:54.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":55,"price":24.6,"value":1353.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":44112,"source":{"system":"sec-edgar","filing":"0001437749-23-003204","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923003204/rdgdoc.xml","form_type":"4"}},{"id":2050091,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-01-21T00:24:33.000Z","date":"2023-01-19","kind":"sale","acquired":false,"shares":374,"price":22.93,"value":8575.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":44167,"source":{"system":"sec-edgar","filing":"0001437749-23-001487","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923001487/rdgdoc.xml","form_type":"4"}},{"id":2058074,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Restricted Stock Award","published_at":"2023-01-11T00:02:47.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":12450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."}],"balance_after":12450,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12450},"source":{"system":"sec-edgar","filing":"0001437749-23-000821","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923000821/rdgdoc.xml","form_type":"4"}},{"id":2058073,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2023-01-11T00:02:47.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":12450,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the \"Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2023 compensation."}],"balance_after":44541,"source":{"system":"sec-edgar","filing":"0001437749-23-000821","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923000821/rdgdoc.xml","form_type":"4"}},{"id":2119102,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2022-11-15T01:03:37.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":38,"price":23.16,"value":880.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":32091,"source":{"system":"sec-edgar","filing":"0001437749-22-027395","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922027395/rdgdoc.xml","form_type":"4"}},{"id":2130086,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2022-11-01T00:00:44.000Z","date":"2022-10-28","kind":"sale","acquired":false,"shares":272,"price":21.76,"value":5918.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":32129,"source":{"system":"sec-edgar","filing":"0001437749-22-025239","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922025239/rdgdoc.xml","form_type":"4"}},{"id":2188605,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2022-08-12T00:00:44.000Z","date":"2022-08-10","kind":"sale","acquired":false,"shares":40,"price":23.17,"value":926.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":32401,"source":{"system":"sec-edgar","filing":"0001437749-22-020213","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922020213/rdgdoc.xml","form_type":"4"}},{"id":2202251,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Comon Stock","published_at":"2022-07-27T00:00:43.000Z","date":"2022-07-22","kind":"sale","acquired":false,"shares":252,"price":17.85,"value":4498.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":32441,"source":{"system":"sec-edgar","filing":"0001437749-22-017814","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922017814/rdgdoc.xml","form_type":"4"}},{"id":2269357,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2022-05-18T00:02:25.000Z","date":"2022-05-13","kind":"sale","acquired":false,"shares":40,"price":12.32,"value":492.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":32693,"source":{"system":"sec-edgar","filing":"0001437749-22-012849","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922012849/rdgdoc.xml","form_type":"4"}},{"id":2292129,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2022-04-23T00:00:28.000Z","date":"2022-04-21","kind":"sale","acquired":false,"shares":325,"price":13.94,"value":4530.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":32733,"source":{"system":"sec-edgar","filing":"0001437749-22-009565","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922009565/rdgdoc.xml","form_type":"4"}},{"id":2343000,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Restricted Stock Award","published_at":"2022-03-10T02:20:29.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":14019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."}],"balance_after":14019,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":14019},"source":{"system":"sec-edgar","filing":"0001437749-22-005772","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922005772/rdgdoc.xml","form_type":"4"}},{"id":2342999,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2022-03-10T02:20:29.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":14019,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the \"Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2022 compensation."}],"balance_after":33058,"source":{"system":"sec-edgar","filing":"0001437749-22-005772","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922005772/rdgdoc.xml","form_type":"4"}},{"id":2399599,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2022-02-15T01:02:50.000Z","date":"2022-02-10","kind":"sale","acquired":false,"shares":197,"price":29.38,"value":5787.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":19039,"source":{"system":"sec-edgar","filing":"0001437749-22-003345","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922003345/rdgdoc.xml","form_type":"4"}},{"id":2428223,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2022-01-25T02:07:31.000Z","date":"2022-01-20","kind":"sale","acquired":false,"shares":332,"price":30.24,"value":10039.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":19236,"source":{"system":"sec-edgar","filing":"0001437749-22-001524","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922001524/rdgdoc.xml","form_type":"4"}},{"id":2536911,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2021-10-23T00:00:25.000Z","date":"2021-10-20","kind":"sale","acquired":false,"shares":272,"price":42.34,"value":11516.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":19568,"source":{"system":"sec-edgar","filing":"0001437749-21-024187","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921024187/rdgdoc.xml","form_type":"4"}},{"id":2627643,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2021-07-23T00:30:44.000Z","date":"2021-07-20","kind":"sale","acquired":false,"shares":1059,"price":45.1,"value":47760.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":19840,"source":{"system":"sec-edgar","filing":"0001437749-21-017394","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921017394/rdgdoc.xml","form_type":"4"}},{"id":2847688,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Restricted Stock Award","published_at":"2021-02-20T01:01:35.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":2795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."}],"balance_after":2795,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2795},"source":{"system":"sec-edgar","filing":"0001437749-21-003516","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921003516/rdgdoc.xml","form_type":"4"}},{"id":2847687,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"officer":true,"officer_title":"VP, Global Human Resources"}}],"security":"Common Stock","published_at":"2021-02-20T01:01:35.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":2795,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the \"Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2021 compensation."}],"balance_after":20899,"source":{"system":"sec-edgar","filing":"0001437749-21-003516","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921003516/rdgdoc.xml","form_type":"4"}}]}